glp 1 for intracranial hypertension GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Aneurysm Rupture and Rupture Severity A glucagon-like peptide-1 receptor agonist

View Study [2]"Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide" Enebo LB et al., 2021 Finding: Phase 1b trial demonstrated that combining cagrilintide with semaglutide 2.4mg resulted in up to 17.1% weight loss at 20 weeks, with the combination being well-tolerated

You still shouldnt crash-lose for muscle and nutrition reasons, but the organ-specific risk is gone, and its fine to feel good about that

In this study, we investigated whether glutathione (GSH) can act as a biofilm disruptor, and enhance antibiotic effectiveness against various bacterial pathogens

If you're uninsured or your plan doesn't cover weight-loss meds, you might consider compounded semaglutide